Adamis Pharmaceuticals Corporation
Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone
Last updated:
Abstract:
The present specification provides compositions of .beta.-endorphin and adrenocorticotropic hormone (ACTH). These compositions are useful in methods of treating disease.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
24 Feb 2022